Evidence map›Paper›PMID 41381866›Full record

ArticleMolecular psychiatry2026

Antidepressant-like effects of extinction learning as an animal model of behavioral therapy.

Jing Liu, Sarah E Bulin, David A Morilak

Abstract read
In one paragraph

Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jing Liu *Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229, USA.
Sarah E Bulin *Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229, USA.ORCID 0000-0003-4730-8291
David A MorilakDepartment of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229, USA. morilak@uthscsa.edu.ORCID 0000-0001-6689-6258

Funding

Prefrontal cortex and stress reactivityR01MH053851 · NIMH · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI MORILAK, DAVID A · 2002 to 2023
$6.4M
BLRD VA I01 BX003512NIMH NIH HHS R01 MH053851U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH053851U.S. Department of Veterans Affairs (Department of Veterans Affairs) I01BX003512
6 · The paper itself

Abstract

Exposure-based behavioral therapy, the most effective treatment for posttraumatic stress disorder (PTSD), also reduces depressive symptoms. However, neurobiological mechanisms underlying the beneficial effects of exposure-based behavioral therapy on depression remain unknown. Our lab has established fear extinction as a rat model of exposure therapy to investigate the mechanisms underlying its therapeutic behavioral effects in chronically stressed rats. In this study, we demonstrated that extinction learning reduced immobility in the forced-swim test and reversed chronic stress-induced reduction in sucrose preference. Chemogenetic inactivation of pyramidal neurons in the ventral medial prefrontal cortex (vmPFC) prevented these antidepressant-like effects of extinction. Extinction learning enhanced synaptic plasticity, reflected by enhanced optogenetically-induced long-term potentiation of mPFC responses evoked by stimulation of the afferent input from the mediodorsal thalamus (MDT). These results suggest that activity-dependent neuroplasticity induced in vmPFC by extinction learning may contribute to its antidepressant-like effects after chronic stress.

Indexed as

Extinction, PsychologicalAnimalsAntidepressive AgentsBehavior, AnimalDepressionDisease Models, AnimalFearLong-Term PotentiationMaleNeuronal PlasticityPrefrontal CortexPyramidal CellsRatsRats, Sprague-DawleyStress Disorders, Post-TraumaticStress, PsychologicalAntidepressive Agents

Identifiers

PMID41381866
PMCPMC12823266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.